Acta neurologica Scandinavica
-
Acta Neurol. Scand. · May 2008
Case ReportsEncephalopathy induced by levetiracetam added to valproate.
We report on the manifestation of a levetiracetam (LEV)-induced encephalopathy. ⋯ Following discontinuation of LEV, EEG and neuropsychological findings improved and seizure frequency decreased.
-
Acta Neurol. Scand. · Apr 2008
Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
We investigated executive function in Parkinson's disease (PD) patients, and focused on executive dysfunction in PD with hallucinations, but without dementia. ⋯ The study suggests that PD patients with hallucinations, not extensive enough to qualify as dementia, already have executive dysfunction similar to that seen in PDD patients. Executive dysfunction may be an important substrate for hallucinations even when dementia is not yet apparent.
-
Acta Neurol. Scand. · Mar 2008
Prevalence of cervicogenic headache: Vågå study of headache epidemiology.
To describe the prevalence and various clinical characteristics of cervicogenic headache (CEH) in the population at large. ⋯ CEH may be one of the three large, recurrent headaches. In this series, there was no female preponderance. Nuchal onset of pain is a characteristic trait.
-
Acta Neurol. Scand. · Feb 2008
Subthreshold depression and cognitive impairment but not demented in stroke patients during their rehabilitation.
Subthreshold depression (sD) and cognitive impairment but not demented (CIND) in stroke patients are associated with poorer rehabilitative outcomes. Their diagnosis can easily be operationalized using validated scales. ⋯ Continuous screening and appropriate intervention, especially at baseline, would significantly decrease the burden posed by stroke patients with such psychological impairments in the community.
-
Acta Neurol. Scand. · Feb 2008
Remifentanil-induced spike activity as a diagnostic tool in epilepsy surgery.
To assess the value of remifentanil in intraoperative evaluation of spike activity in patients undergoing surgery for mesial temporal lobe epilepsy (MTLE). ⋯ The results suggest that remifentanil can enhance spike activity in the epileptogenic zone and reveal otherwise concealed epileptogenic tissue in patients with MTLE. Thus, remifentanil may prove to be an important diagnostic tool during surgical treatment for intractable focal epilepsy.